This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): JDP205
Description: JDP205 is a small molecule, non-sedating antihistamine.
JDP and Hospira
On March 2016, JDP announced that it entered into a development, manufacture and supply agreement, for JDP-205, with Hospira (a Pfizer company). Under this agreement, Hospira will be responsible for the remaining CMC activities for JDP-205s NDA, including development and manufacture of JDP-205s registration & Phase III clinical batches; Hospira will also be responsible for manufacture and supply of commercial quantities of JDP- 205.
Partners: JDP Therapeutics, Inc.
Scrip JDP Therapeutics Inc.
Additional information available to subscribers only: